Lung Diseases, Interstitial: all 656 studies

Page 3 of 7. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.

• Screening of Patients With Rheumatoid Arthritis for Interstitial Lung DiseaseRecruitingNCT05391100
• Pulmonary Fibrosis Foundation Community RegistryRecruitingNCT05382572
• Registry of Autoimmune Interstitial Lung DiseaseRecruitingNCT05365009
• Interstitial Lung Disease Trajectories in Patients With Systemic SclerosisRecruitingNCT05345795
• Deep Learning Diagnostic and Risk-stratification for IPF and COPDRecruitingNCT05318599
• Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney TransplantationEnrolling by invitationNCT05285878Phase 2
• Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related CoughRecruitingNCT05120934Phase 2
• Study of Hospitalised Patients With Acute Respiratory ConditionsRecruitingNCT05095090
• ILD-SARDs Registry and BiorepositoryRecruitingNCT05007340
• Global Utilization And Registry Database for Improved preservAtion of doNor LUNGsEnrolling by invitationNCT04930289
• Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung DiseaseRecruitingNCT04925375Phase 2
• Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung DiseaseEnrolling by invitationNCT04905693Phase 3
• University of Virginia Natural History StudyEnrolling by invitationNCT04896138
• A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint BlockadeRecruitingNCT04807127
• A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLCRecruitingNCT04807114
• Pulmonary Hypertension SOLARRecruitingNCT04778046Phase 2
• Thorax MRI for Evaluation of Lung Morphology, Ventilation and PerfusionNot yet recruitingNCT04719078Not applicable
• Database for Interstitial Lung DiseaseRecruitingNCT04707781
• Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary DiseaseRecruitingNCT04624490Phase 1
• Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic CausesRecruitingNCT04532346Early Phase 1
• Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT)RecruitingNCT04328181Not applicable
• An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth TechnologyRecruitingNCT04304898
• Effects of Drinking Beetroot Juice on Exercise Performance in Patients With Fibrotic Interstitial Lung DiseaseRecruitingNCT04299945Not applicable
• TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT PatientsRecruitingNCT04098445
• Connective Tissue Diseases and Lung ManifestationsRecruitingNCT04095351
• The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) StudyEnrolling by invitationNCT04016181
• Clinical Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF) - a Multicenter Prospective StudyNot yet recruitingNCT03870828
• Skeletal Muscle Function in Interstitial Lung DiseaseRecruitingNCT03800017Not applicable
• Autologous Stem Cell Transplantation in Patients With Systemic SclerosisRecruitingNCT03630211Phase 2
• Comparison of PR Efficiency in Home-based With Hospital-based PR in BronchiectasisRecruitingNCT03561818Not applicable
• Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)RecruitingNCT03478826
• Rheumatoid Arthritis Patients at Risk for Interstitial Lung DiseaseRecruitingNCT03297775
• WTC Chest CT Imaging ArchiveEnrolling by invitationNCT03295279
• European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and BiobankRecruitingNCT02852928
• Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes RegistryRecruitingNCT01915511
• Prospective Data Collection of Patients With Diffuse Parenchymal Lung DiseasesRecruitingNCT01600378
• Hyperpolarized 129Xe MRI for Imaging Pulmonary FunctionRecruitingNCT01280994Phase 2
• Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT01088217
• A Study of the Natural Progression of Interstitial Lung Disease (ILD)RecruitingNCT00470327
• Dorothy P. and Richard P. Simmons Center for ILD Research RegistryRecruitingNCT00258583
• Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung DiseaseCompletedNCT05957198Results posted
• Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT05938920Phase 2Results posted
• Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and TreatmentCompletedNCT05875532Results posted
• Usability and Acceptability Study of the P-STEP Mobile ApplicationCompletedNCT05830318Results posted
• Myositis Interstitial Lung Disease Nintedanib TrialCompletedNCT05799755Phase 4Results posted
• A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary HypertensionCompletedNCT05564637Phase 2Results posted
• A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)CompletedNCT05321082Phase 3Results posted
• A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON)CompletedNCT05285982Phase 3Results posted
• Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisCompletedNCT05255991Phase 3Results posted
• Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study).CompletedNCT05128929Phase 2Results posted
• A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung FibrosisCompletedNCT05065190Phase 3Results posted
• Goals of Care Conversations StudyCompletedNCT05001009Not applicableResults posted
• Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung DiseaseCompletedNCT04855305Phase 2Results posted
• A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease PatientsTerminatedNCT04837131Phase 2Results posted
• INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world EvaluationCompletedNCT04702893Results posted
• LYT-100 in Post-acute COVID-19 Respiratory DiseaseTerminatedNCT04652518Phase 2Results posted
• The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19CompletedNCT04619680Phase 4Results posted
• Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in JapanCompletedNCT04559581Results posted
• Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease.CompletedNCT04413149Results posted
• A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung FibrosisCompletedNCT04308681Phase 2Results posted
• Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)CompletedNCT04283994Not applicableResults posted
• Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)CompletedNCT04281784Not applicableResults posted
• A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)CompletedNCT04093024Phase 3Results posted
• Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILDTerminatedNCT03901534Not applicableResults posted
• A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)CompletedNCT03820726Phase 3Results posted
• A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)CompletedNCT03675581Phase 1Results posted
• Families-At-risk for Interstitial Lung Disease StudyCompletedNCT03641742Results posted
• A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung FibrosisCompletedNCT03313180Phase 3Results posted
• A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic PeriodCompletedNCT03261037Not applicableResults posted
• Scleroderma Lung Study III - Combining Pirfenidone With MycophenolateCompletedNCT03221257Phase 2Results posted
• Abatacept for the Treatment of Myositis-associated Interstitial Lung DiseaseCompletedNCT03215927Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary FibrosisTerminatedNCT03142191Phase 2Results posted
• A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung DiseaseCompletedNCT03099187Phase 2Results posted
• Assessment of Lung Movement With Computed Tomography (CT)CompletedNCT03068091Not applicableResults posted
• Autologous Stem Cell Treatment for Chronic Lung Disease StudyCompletedNCT03044431Results posted
• An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung DiseaseCompletedNCT03040674Results posted
• Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)CompletedNCT02999178Phase 3Results posted
• Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity PneumonitisTerminatedNCT02958917Phase 2Results posted
• Hepatitis C Virus(HCV) Heart and Lung StudyCompletedNCT02858180Phase 4Results posted
• Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease (SAD-COPD)TerminatedNCT02813447Not applicableResults posted
• Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)CompletedNCT02808871Phase 2Results posted
• Abituzumab in SSc-ILDTerminatedNCT02745145Phase 2Results posted
• Advancing Symptom Alleviation With Palliative TreatmentCompletedNCT02713347Not applicableResults posted
• An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFETerminatedNCT02633293Phase 2/3Results posted
• Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFECompletedNCT02630316Phase 2/3Results posted
• Hydroxychloroquine (HCQ) in Pediatric Interstitial Lung Disease (ILD)TerminatedNCT02615938Phase 2Results posted
• Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary FibrosisCompletedNCT02370693Phase 2Results posted
• Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)TerminatedNCT02138825Phase 2Results posted
• Novartis Everolimus TransitionCompletedNCT02096107Phase 4Results posted
• Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIATCompletedNCT02036970Phase 2Results posted
• The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung DiseaseCompletedNCT02019641Not applicableResults posted
• Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung DiseaseCompletedNCT01948518Not applicableResults posted
• Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)CompletedNCT01933334Phase 2Results posted
• Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung DiseaseTerminatedNCT01559129Phase 2Results posted
• Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary FibrosisCompletedNCT01442779Phase 2Results posted
• A Clinical Trial for CTD-ILD TreatmentTerminatedNCT01424033Phase 2/3Results posted
• GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic DiseasesTerminatedNCT01257802Phase 3Results posted
• Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant RecipientsCompletedNCT01079143Phase 3Results posted
• Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)CompletedNCT00883129Phase 2Results posted
• Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial HypertensionCompletedNCT00705133Phase 2Results posted

← Lung Diseases, Interstitial overview